Skip to content

NYXH

Nyxoah SA

NASDAQ · Healthcare · Medical - Instruments & Supplies · BE

$0.89
−1.34%
Ask drillr

Year over year

Reported trailing growth

Revenue
+359.2%
EBITDA
-7.0%
EBIT
-17.6%
EPS
-2.8%
Free cash flow
-15.5%
Operating cash flow
-17.9%

Forward estimates

Based on analyst estimates

Revenue
+202.3%
EBITDA
+77.7%
EPS
+59.6%

Three-year CAGR

Revenue
+48.1%
EBITDA
-60.0%
EBIT
-41.0%
Net income
-52.1%
EPS
-30.4%
Free cash flow
-23.5%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026